We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Insights Into Altria (MO) Q3: Wall Street Projections for Key Metrics
Read MoreHide Full Article
The upcoming report from Altria (MO - Free Report) is expected to reveal quarterly earnings of $1.51 per share, indicating an increase of 4.1% compared to the year-ago period. Analysts forecast revenues of $5.3 billion, representing an increase of 1% year over year.
The consensus EPS estimate for the quarter has undergone a downward revision of 0.3% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
In light of this perspective, let's dive into the average estimates of certain Altria metrics that are commonly tracked and forecasted by Wall Street analysts.
Analysts predict that the 'Revenues net of excise taxes- Oral Tobacco Products' will reach $694.43 million. The estimate suggests a change of +4.4% year over year.
Analysts forecast 'Revenues net of excise taxes- Smokeable Products' to reach $4.62 billion. The estimate indicates a year-over-year change of +0.6%.
The combined assessment of analysts suggests that 'Operating Companies Income- Reported OCI- Oral Tobacco Products' will likely reach $467.09 million. Compared to the current estimate, the company reported $459.00 million in the same quarter of the previous year.
Analysts' assessment points toward 'Operating Companies Income- Adjusted OCI- Smokeable Products' reaching $3.02 billion. Compared to the current estimate, the company reported $2.96 billion in the same quarter of the previous year.
Shares of Altria have demonstrated returns of +8% over the past month compared to the Zacks S&P 500 composite's -1.2% change. With a Zacks Rank #2 (Buy), MO is expected to beat the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
View the Zacks #1 Rank List
Image: Bigstock
Insights Into Altria (MO) Q3: Wall Street Projections for Key Metrics
The upcoming report from Altria (MO - Free Report) is expected to reveal quarterly earnings of $1.51 per share, indicating an increase of 4.1% compared to the year-ago period. Analysts forecast revenues of $5.3 billion, representing an increase of 1% year over year.
The consensus EPS estimate for the quarter has undergone a downward revision of 0.3% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
In light of this perspective, let's dive into the average estimates of certain Altria metrics that are commonly tracked and forecasted by Wall Street analysts.
Analysts predict that the 'Revenues net of excise taxes- Oral Tobacco Products' will reach $694.43 million. The estimate suggests a change of +4.4% year over year.
Analysts forecast 'Revenues net of excise taxes- Smokeable Products' to reach $4.62 billion. The estimate indicates a year-over-year change of +0.6%.
The combined assessment of analysts suggests that 'Operating Companies Income- Reported OCI- Oral Tobacco Products' will likely reach $467.09 million. Compared to the current estimate, the company reported $459.00 million in the same quarter of the previous year.
Analysts' assessment points toward 'Operating Companies Income- Adjusted OCI- Smokeable Products' reaching $3.02 billion. Compared to the current estimate, the company reported $2.96 billion in the same quarter of the previous year.
View all Key Company Metrics for Altria here>>>Shares of Altria have demonstrated returns of +8% over the past month compared to the Zacks S&P 500 composite's -1.2% change. With a Zacks Rank #2 (Buy), MO is expected to beat the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .